Please assess the completion status of the following clinical trial:

Trial Title: Analgesia for 2nd Trimester Termination of Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* interruption of pregnancy between 12 and 23 6/7 weeks~Exclusion Criteria:~* documented allergy to fentanyl or bupivacaine~* coagulopathy~* drug or narcotic abuse~* contraindication to neuraxial analgesia~* inability to comply with IVPCA or PCEA~* inability to complete the QoR-40 questionnaire~* TOP due to maternal problems

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Epidural (PCEA) (Type: ACTIVE_COMPARATOR): bupivacaine, fentanyl
- IV PCA (Type: ACTIVE_COMPARATOR): Intravenous fentanyl patient controlled analgesia

Based on this trial design, predict the completion outcome and termination type (if applicable).